Fortitude Advisory Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$456K Sell
1,258
-18
-1% -$6.16K 0.17% 116
2026
Q1
$449K Sell
1,276
-15
-1% -$5.35K 0.2% 108
2025
Q4
$423K Sell
1,291
-2
-0.2% -$634 0.18% 96
2025
Q3
$365K Buy
1,293
+63
+5% +$18.3K 0.2% 108
2025
Q2
$343K Buy
1,230
+2
+0.2% +$567 0.2% 114
2025
Q1
$347K Sell
1,228
-59
-5% -$17.4K 0.25% 94
2024
Q4
$336K Sell
1,287
-328
-20% -$97.3K 0.2% 110
2024
Q3
$520K Sell
1,615
-19
-1% -$6.21K 0.33% 66
2024
Q2
$511K Sell
1,634
-306
-16% -$89.9K 0.31% 65
2024
Q1
$552K Sell
1,940
-371
-16% -$109K 0.31% 71
2023
Q4
$666K Buy
2,311
+99
+4% +$27K 0.4% 50
2023
Q3
$595K Buy
2,212
+45
+2% +$11.2K 0.4% 53
2023
Q2
$481K Buy
2,167
+2
+0.1% +$464 0.35% 67
2023
Q1
$523K Buy
2,165
+73
+3% +$17.9K 0.41% 60
2022
Q4
$549K Sell
2,092
-59
-3% -$15.8K 0.47% 59
2022
Q3
$485K Sell
2,151
-32
-1% -$7.76K 0.46% 56
2022
Q2
$531K Sell
2,183
-196
-8% -$48K 0.49% 50
2022
Q1
$575K Buy
2,379
+1,297
+120% +$298K 0.31% 49
2021
Q4
$487K Buy
+1,082
New +$228K 0.25% 68

Other funds holding AMGN

Fortitude Advisory Group's AMGN Position: Q2 2026 in Review

Fortitude Advisory Group reduced its Amgen (AMGN) stake by 1.4% in Q2 2026, selling an estimated $6.16K and leaving 1,258 shares worth $456K. The position accounts for 0.17% of the portfolio, ranked #116.

Fortitude Advisory Group first reported a position in AMGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $666K in Q4 2023. 1,278 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Fortitude Advisory Group held 1,258 shares of Amgen worth $456K as of Q2 2026.
  • Fortitude Advisory Group sold 18 Amgen shares in Q2 2026, an estimated $6.16K.
  • Amgen made up 0.17% of Fortitude Advisory Group's portfolio in Q2 2026, its #116 holding.
  • Fortitude Advisory Group first reported a position in Amgen in Q4 2021 and has held it in 19 quarters since.
  • Fortitude Advisory Group's Amgen position peaked at $666K in Q4 2023.
  • 1,278 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Fortitude Advisory Group's 13F filing for Q2 2026, filed 22 Jul 2026.